Chlamydia pneumoniae and atherosclerosis: The role of mast cells

Journal of Biological Regulators and Homeostatic Agents

Volumn 23, Issue 2, 2009, Pages 65-69

  Di Pietro, M ^a   Schiavoni, G ^a   Del Piano, M ^a   Shaik, Y ^b   Boscolo, P ^c   Caraffa, A ^d   Grano, M ^e   Tete S ^c   Conti, F ^c   Sessa, R ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CHIETI   (Italy)

^d UNIVERSITY OF PERUGIA   (Italy)

^e UNIVERSITY OF BARI   (Italy)

Author keywords

Chlamydia pneumoniae; Inflammation; Innate immunity; Mast cells

Indexed keywords

ASTHMA; ATHEROSCLEROSIS; CELL ACTIVATION; CHLAMYDIAL PNEUMONIA; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERY DISEASE; HEART INFARCTION; INNATE IMMUNITY; MAST CELL; PATHOPHYSIOLOGY; REVIEW; CHLAMYDIASIS; EDITORIAL; HUMAN; IMMUNOLOGY; INFLAMMATION; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY;

CHLAMYDOPHILA PNEUMONIAE;

ATHEROSCLEROSIS; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MAST CELLS;

EID: 73349100386     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Kern JM, Maass V, Maass M. Chlamydia pneumoniae-induced pathological signaling in the vasculature. FEMS Immunol Med Microbiol 2009; 55:131-139
2. Sessa R, Cipriani P, Di Pietro M, Schiavoni G, Santino I, del Piano M. Chlamydia pneumoniae and chronic diseases with a great impact on public health. Int J Immunopathol Pharmacol 2008; 21:1041-1043
3. Marino J, Stoeckli I, Walch M, Latinovic-Golic S, Sundstroem H, Groscurth P, Ziegler U, Dumrese C. Chlamydophila pneumoniae derived from inclusions late in the infectious cycle induce aponecrosis in human aortic endothelial cells. BMC Microbiol 2008; 19:8-32. (Pubitemid 351661406)
4. Ciervo A, Mancini F, Sale P, Russo A, Cassone A. Real-time polymerase chain reaction and laser capture microdissection: an efficient combination tool for Chlamydophila pneumoniae DNA quantification and localization of infection in atherosclerotic lesions. Int J Immunopathol Pharmacol 2008; 21:421-428 (Pubitemid 351988407)
5. Bobryshev YV, Killingsworth MC, Tran D, Lord R. Amalgamation of Chlamydia pneumoniae inclusions with lipid droplets in foam cells in human atherosclerotic plaque. Virchows Arch 2008; 453:69-77.
6. Sessa R, Di Pietro M, Schiavoni G, Petrucca A, Cipriani P, Zagaglia C, Nicoletti M, Santino I, del Piano M. Measurement of Chlamydia pneumoniae bacterial load in peripheral blood mononuclear cells may be helpful to assess the state of chlamydial infection in patients with carotid atherosclerotic disease. Atherosclerosis 2007; 195:e224-30. (Pubitemid 47561974)
7. Mei CL, He P, Cheng B, Liu W, Wang YF, Wan JJ. Chlamydia pneumoniae induces macrophage-derived foam cell formation via PPAR alpha and PPAR gamma-dependent pathways. Cell Biol Int 2009; 33:301-308
8. Villegas E, Sorlózano A, Camacho A, Gutiérrez J. Chlamydophila pneumoniae: from proteomics to arteriosclerosis. Enferm Infecc Microbiol Clin 2008; 26:629-637
9. Galliera E, Locati M, Mantovani A. Corsi MM. Chemokines and bone remodeling. Int J Immunopathol Pharmacol 2008; 21:485-492
10. Sessa R, Nicoletti M, Di Pietro M, Schiavoni G, Santino I, Zagaglia C, del Piano M, Cipriani P. Chlamydia pneumoniae and atherosclerosis: current state and future prospectives. Int J Immunopathol Pharmacol 2009; 22:9-14.
11. Chen S, Sorrentino R, Shimada K, Bulut Y, Doherty TM, Crother TR, Arditi M. Chlamydia pneumoniae-induced foam cell formation requires MyD88-dependent and -independent signaling and is reciprocally modulated by liver X receptor activation. J Immunol 2008; 181:7186-7193
12. Theoharides TC, Makris M, Kalogeromitros D. Allergic inflammation and adipocytokines. Int J Immunopathol Pharmacol 2008; 21:1-4
13. Di Marzio L, Cinque B, Cupelli F, De Simone C, Cifone MG, Giuliani M. Increase of skin-ceramide levels in aged subjects following a short-term topical application of bacterial sphingomyelinase from Streptococcus thermophilus. Int J Immunopathol Pharmacol 2008; 21:137-144 (Pubitemid 351501009)
14. Kalayoglu MV, Indrawati, Morrison RP, Morrison SG, Yuan Y, Byrne GI. Chlamydial virulence determinants in atherogenesis: the role of chlamydial lipopolysaccharide and heat shock protein 60 in macrophage-lipoprotein interactions. J Infect Dis 2000; 181:S483-9. (Pubitemid 30416125)
15. Yaraei K, Campbell LA, Zhu X, Liles WC, Kuo CC, Rosenfeld ME. Chlamydia pneumoniae augments the oxidized low-density lipoprotein-induced death of mouse macrophages by a caspase-independent pathway. Infect Immun 2005; 73:4315-4322 (Pubitemid 40923176)
16. Rizzo A, Paolillo R, Lanza AG, Guida L, Annunziata M, Carratelli CR. Chlamydia pneumoniae induces interleukin-6 and interleukin-10 in human gingival fibroblasts. Microbiol Immunol 2008; 52:447-454
17. Di Vita G, Patti R, Sparacello M, Balistreri CR, Candore G, Caruso C. Impact of different texture of polypropylene mesh on the inflammatory response. Int J Immunopathol Pharmacol 2008; 21:207-214 (Pubitemid 351501017)
18. Kälvegren H, Majeed M, Bengtsson T. Chlamydia pneumoniae binds to platelets and triggers P-selectin expression and aggregation: a causal role in cardiovascular disease? Arterioscler Thromb Vasc Biol 2003; 23:1677-1683
19. Hoymans VY, Bosmans JM, Ieven MM, Vrints CJ. Chlamydia pneumoniae-based atherosclerosis: a smoking gun. Acta Cardiol 2007; 62:565-571
20. Sawayama Y, Tatsukawa M, Maeda S, Ohnishi H, Furusyo N, Hayashi J. Association of hyperhomocysteinemia and Chlamydia pneumoniae infection with carotid atherosclerosis and coronary artery disease in Japanese patients. J Infect Chemother 2008; 14:232-237 (Pubitemid 351875921)
21. Cirillo N, Lanza M, De Rosa A, Femiano F, Gombos F, Lanza A. At least three phosphorylation events induced by pemphigus vulgaris sera are pathogenically involved in keratinocyte acantholysis. Int J Immunopathol Pharmacol 2008; 21:189-196 (Pubitemid 351501015)
22. Halvorsen B, Otterdal K, Dahl TB, Skjelland M, Gullestad L, Øie E, Aukrust P. Atherosclerotic plaque stability - what determines the fate of a plaque? Prog Cardiovasc Dis 2008; 51:183-194
23. Jha HC, Srivastava P, Sarkar R, Prasad J, Mittal A. Chlamydia pneumoniae IgA and elevated level of IL-6 may synergize to accelerate coronary artery disease. J Cardiol 2008; 52:140-145
24. Volanen I, Kallio K, Saarinen M, et al. Arterial intima-media thickness in 13-year-old adolescents and previous antichlamydial antimicrobial use: a retrospective follow-up study. Pediatrics 2008; 122:e675-81.
25. Vivas JR, Regnault B, Michel V, et al. Interferon gamma-signature transcript profiling and IL-23 upregulation in response to Helicobacter pylori infection. Int J Immunopathol Pharmacol 2008; 21:515-526
26. Katsanos GS, Anogeianaki A, Orso C, Tet□S, Salini V, Antinolfi PL, Sabatino G. Mast cells and chemokines. J Biol Regul Homeost Agents 2008; 22:145-151
27. Bossone E, Trimarchi S, Esposito G, Aliberti S, Citro R, Allegra L, Blasi F. Chlamydia pneumoniae and acute aortic syndrome: a call for a multi-institutional study. Monaldi Arch Chest Dis 2008; 70:68-70.
28. Lindstedt KA, Mayranpaa MI, Kovanen PT. Mast cells in vulnerable atherosclerotic plaques - a view to a kill. J Cell Mol Med 2007; 11:739-758
29. Berlutti F, Superti F, Nicoletti M, Morea C, Frioni A, Ammendolia MG, Battistoni A, Valenti P. Bovine lactoferrin inhibits the efficiency of invasion of respiratory A549 cells of different iron-regulated morphological forms of Pseudomonas aeruginosa and Burkholderia cenocepacia Int J Immunopathol Pharmacol 2008; 21:51-60.
30. Kovanen PT. Mast cells and degradation of pericellular and extracellular matrices: potential contributions to erosion, rupture and intraplaque haemorrhage of atherosclerotic plaques. Biochem Soc Trans 2007; 35:857-861
31. Watson C, Alp NJ. Role of Chlamydia pneumoniae in atherosclerosis. Clin Sci (Lond) 2008; 114:509-31.
32. Inoue K, Takano H, Yanagisawa R, Sakurai M, Shimada A, Satoh M, Yoshino S, Yamaki K, Yoshikawa T. Antioxidative role of interleukin-6 in septic lung injury in mice. Int J Immunopathol Pharmacol 2008; 21:501-508
33. Lalle E, Sacchi A, Abbate I, et al. Activation of interferon response genes and of plasmacytoid dendritic cells in HIV-1 positive subjects with GB virus C co-infection. Int J Immunopathol Pharmacol 2008; 21:161-172 (Pubitemid 351501012)
34. Hu CL, Xiang JZ, Hu FF, Huang CX. Adventitial inflammation: a possible pathogenic link to the instability of atherosclerotic plaque. Med Hypotheses 2007; 68:1262-1264
35. Deviri E, Glenville BE. Inflammatory response in infective endocarditis. Eur J Inflamm 2007; 5:57-63.
36. Stassi G, Cascio A, Iaria C, Gazzara D, Costa GB, Iannello D, Arena A. Modulation of GRO-α and TNF-α production by peripheral blood mononuclear cells treated with killed Helicobacter pylori. Eur J Inflamm 2007; 5:83-87 (Pubitemid 47288051)
37. Ghoneum M, Matsuura M, Gollapudi S. Modified arabinoxylan rice bran (mgn-3/biobran) enhances intracellular killing of microbes by human phagocytic cells in vitro. Int J Immunopathol Pharmacol 2008; 21:87-96. (Pubitemid 351501004)
38. Oksaharju A, Lappalainen J, Tuomainen AM, Pussinen PJ, Puolakkainen M, Kovanen PT, Lindstedt KA. Proatherogenic lung and oral pathogens induce an inflammatory response in human and mouse mast cells. J Cell Mol Med 2008; 13:103-113
39. Gelardi M, Maselli del Giudice A, Fiorella ML, et al. Quality of life in non-allergic rhinitis depends on the predominant inflammatory cell type. J Biol Regul Homeost Agents 2008; 22:73-81. (Pubitemid 351577895)
40. Laine P, Kaartinen M, Penttilä A, Panula P, Paavonen T, Kovanen PT. Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. Circulation 1999; 99:361-369 (Pubitemid 29051261)
41. Reszka E, Jegier B, Wasowicz W, Lelonek M, Banach M, Jaszewski R. Cardiovasc Detection of infectious agents by polymerase chain reaction in human aortic wall. Pathol 2008; 17:297-302.
42. Tullio V, Cuffini AM, Banche G, et al. Role of fosfomycin tromethamine in modulating non-specific defence mechanisms in chronic uremic patients towards ESBL-producing Escherichia coli. Int J Immunopathol Pharmacol 2008; 21:153-160 (Pubitemid 351501011)
43. Deepak P, Kumar S, Acharya A. IL-13 neutralization modulates function of type II polarized macrophages in vivo in a murine T-cell lymphoma. Eur J Inflamm 2007; 5:37-45. (Pubitemid 46779253)
44. Ronchetti R, Jesenak M, Barberi S, Ronchetti F, Rennerova Z, Trubacova D, Villa MP. Reproducibility of atopy patch tests with food and inhalant allergens. J Biol Regul Homeost Agents 2008; 22:27-33. (Pubitemid 351577890)
45. Tsuruda T, Kato J, Hatakeyama K, et al. Adventitial mast cells contribute to pathogenesis in the progression of abdominal aortic aneurysm. Circ Res 2008; 102:1368-1377
46. Guan XR, Li X, Xin XM, Jiang LX, Cui LY, Wang LF, Li HY. Influenza virus infection and risk of acute myocardial infarction. Inflammation 2008; 31:266-72.
47. Riccio A, Postiglione L, La Dogana P, Spano A, Marzocchella C, Tarantino G. Anti-cyclic citrullinated peptide antibodies in patients affected by HCV-related arthritis. J Biol Regul Homeost Agents 2008; 22:57-61 (Pubitemid 351577893)
48. Iriz E, Cirak MY, Engin ED, Zor MH, Erer D, Imren Y, Turet S, Halit V. Effects of atypical pneumonia agents on progression of atherosclerosis and acute coronary syndrome. Acta Cardiol 2007; 62:593-598 (Pubitemid 350250547)
49. Wedemeyer J, Tsai M, Galli SJ. Roles of mast cells and basophils in innate and acquired immunity. Curr Opin Immunol 2000; 12:624-631
50. Xu X, Zhang D, Zhang H, et al. Neutrophil histamine contributes to inflammation in mycoplasma pneumonia. J Exp Med 2006; 203:2907-2917 (Pubitemid 46026168)
51. Kalogeromitros D, Makris M, Chliva C, Aggelides X, Kempuraj D, Theoharides TC. A quercetin containing supplement reduces niacin-induced flush in humans. Int J Immunopathol Pharmacol 2008; 21:509-514
52. Vojdani A. Antibodies as predictors of complex autoimmune diseases and cancer. Int J Immunopathol Pharmacol 2008; 21:553-566 (Pubitemid 351988388)
53. Martin RJ, Kraft M, Chu HW, Berns EA, Cassell GH. A link between chronic asthma and chronic infection. J Allergy Clin Immunol 2001; 107:595-601.
54. Sonneck K, Baumgartner C, Rebuzzi L, et al. Recombinant allergens promote expression of aminopeptidase-n (CD13) on basophils in allergic patients Int J Immunopathol Pharmacol 2008; 21:11-22.